This paper surveys recent, as yet unpublished, statistical studies arising from research in genetic toxicology within the U.S. National Toxicology Program (NTP). These studies all involve analyses of data from Ames Salmonella/microsome mutagenicity tests, but the statistical methodologies are broadly applicable. Three issues are addressed: First, what is a tenable sampling model for Ames test data, and how does one best test the adequacy of the Poisson sampling assumption? Second, given that nonmonotone dose-response curves are fairly common in the Salmonella assay, what new statistical techniques or modifications of existing ones seem appropriate to accommodate to this reality? Finally, an intriguing question: How can the extensive NTP Ames test data base be used to assess the characteristics of any mutagen-nonmutagen decision rule? The last issue is illustrated with the commonly used "two-times background" rule.
Introduction
During the last decade the science of genetic toxicology has experienced dramatic growth in its volume of experimentation, its variety of assays, and the level of public awareness of it. Even laymen are likely to have heard of some of the tests in this field or seen newspaper accounts of results from one. This growth, in all its dimensions, is attributable to the ability of these test systems to detect, rapidly and relatively inexpensively, environmental agents that are genotoxic; these agents are thought to be implicated in such diverse human health problems as cancer, aging, and birth defects (1) . It is reputed that over 2000 laboratories worldwide, in industry, academia, and government, currently perform the Ames Salmonella/microsome test (2) , the best known and most widely employed of the short-term tests for genetic toxicity. In many parts of the industrialized world, regulatory decisions regarding the registration of pesticides or pharmaceuticals are based in part on results from tests for genetic toxicity. In some countries, such as Japan and the United States, these tests are used in national programs to screen agents already in the environment. It is worth remembering, however, that this area of scientific research is far from mature; much remains to be achieved in terms of understanding the precise implications ofresults from such tests for the assessment of risks to human health. To date, man-made industrial agents have been the primary focus of research interest in this area; there is, however, an increasing emphasis on naturally occurring potential sources of genetic toxicity, such as common dietary components. The term "genetic toxicity" is applied to the induction of genetic damage by any agent, whether the damage be DNA point mutations at a particular locus, induction of DNA repair, binding to DNA, or chromosomal aberrations, such as fragments or aneuploidy. The chronic rodent carcinogenicity bioassay, technically speaking, is not a test for genetic toxicity because tumor development has not yet been demonstrated to result directly from genetic damage. The somatic-mutation theory of cancer (3) , however, is seemingly reinforced weekly by new experimental findings.
Unlike the chronic rodent carcinogenicity bioassay, for which there is a rich statistical literature, the tests for genetic toxicity have only recently begun to attract the attention of research statisticians; witness the dearth of published papers containing new statistical methodology motivated wholly or in part by problems in genetic toxicology. Two exceptions are the works by Collings, Margolin and Oehlert (4) on the analysis of binomial data and by Tarone (5) on the use of historical control data. Although five years ago Hollstein et al. (6) , in an excellent review of short-term tests for genetic toxicity, could cite over 100 assays that had at least a modicum of representation in the published literature, the U.S. National Toxicology Program (NTP) has fewer than 20 assays in use, undergoing validation or in de- (10) Although control trials are highly useful, they are rarely available. In general, even a good-sized random sample of control plates is hard to come by. For example, the data of Margolin et al. (8, 10) are unique in the literature on the Ames test.
For the general short-term test in which unbounded count data are observed, the test results that would be available for assessing the goodness of fit of the Poisson assumption are from experiments with varying doses of true test compounds. These data are not identically distributed, but rather have a one-way layout structure indexed by dose. An extension to the one-way layout of the goodness of fit test for Poisson sampling based on Eq. (1) is studied by Collings and Margolin (10) , who obtain the following result. The null sampling distribution of Tc and the power of the test based upon it were also studied (10).
The theorem above generalizes a result obtained by Potthoff and Whittinghill (13) (2) for y = 0, 1, 2, ..., 0 < m < x, and 0 < c < o. As a shorthand, Y will be said to be distributed NB (m,c) if (4) and reference a chi-square distribution with (Xni) -r degrees of freedom. Collings and Margolin (10) The modification of the Cochran-Armitage trend test needed to permit its use for negative binomial data is to define sx2 = X(1 + cX), where c is the MLE of c in Eq. (2) when the data are considered as a random sample (HO). Again, the reference distribution for Z is the standard normal. The Appendix contains a demonstration paralleling that ofTarone (5), which establishes that the test for trend among negative binomial means is asymptotically locally optimal against any smooth monotone function that expresses m in terms of d. As Collings and Margolin (10) note, the negative binomial distribution in Eq. (2) can be extended to include the binomial as well as the Poisson distribution. The Appendix then contains a proof that holds for all three models. Table 1 presents results from a small Monte Carlo study of the size of the one-tailed test for trend in negative binomial means. To mimic typical experimentation, the Monte Carlo included six dose groups, with either three or five replicate observations per dose. The dosing was either linear (specified by d = 0, 1, . . ., 5) or logarithmic (specified by d = 0, 1, 10,. .., 104). Note that these specifications entail no loss in generality because Eq. (6) is invariant to scale transformations of dose. The values for m were set at 15 and 150, whereas c was either 0 (Poisson) or 3/m (highly overdispersed). Each of the 1000 data sets randomly generated for a given set of conditions was analyzed two ways, once with the true c used in s,, in Eq. (6) and once with the MLE of c, as would be the case with real data. The results indicate that the size of the trend test is well approximated by the standard normal tail area whether c is known or estimated from the data.
A more interesting characteristic of Ames test data that separates them from most other dose response data treated in the statistics literature is that the dose-response for Ames test data is frequently not monotone (8) . There are other in vitro assays for genetic toxicity that exhibit similar behavior, e.g., the fluctuation test (4) and the mouse lymphoma assay (personal communication from W. Caspary, NTP). The common decrease in mean response at high doses, sometimes to levels below that for the control, is usually attributed to toxicity that prevents an experimental unit from exhibiting phenotypic evidence of mutagenicity. Decreases in the mean response at high doses, especially to or below control levels, impact heavily on the power of trend tests (4), which place their greatest weight on the responses to the control and maximum dose. Three (17) , has been advocated for analyzing data from short-term tests for genetic toxicity (18, 19 
External Validation of Tests of Hypothesis
One further important way in which the Ames Salmonella assay is unusual is in its sheer volume of usage; because the assay is fast and relatively inexpensive, it lends itself nicely to screening efforts. Since its creation in 1978, the NTP has had as one of its broad goals the extensive screening of environmental agents for evidence of genetic toxicity. To date, the data collected have come overwhelmingly from Ames tests on four strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537) tested separately at each of three levels of metabolic activation: rat liver, hamster liver, or none. The two mammalian liver (S9) preparations represent an attempt to recreate in vitro the metabolic processes that occur in humans. It is well known that apparently innocuous chemicals can be converted in vivo into noxious metabolites, so the use of an S9 activation attempts to provide for this possibility.
Chemicals are nominated in many different ways for NTP testing. If the scientific interest or evidence for concern is sufficient to justify the experimentation, the selected chemical proceeds through a 12 strain-activation battery of tests. The NTP Salmonella/microsome database currently consists of over 24,000 experiments, where an experiment refers to a test with a particular chemical, strain and activation in a given laboratory on f(Yi;p,Ti) = zib(Yi;ni,p) + (1 -zi) b(Yi;ni,Ti); (7) where b(x;n,4) is the binomial probability distribution function for x successes out of n trials with success probability +; zi is an indicator variable with value 1 for nonmutagenicity and 0 for mutagenicity of chemical i in the particular strain/activation; p is the true probability that an experiment with a nonmutagen in the particular strain/activation will yield a result judged positive by the decision rule; Ti is the probability that an experiment with the particular strain/activation for chemical i, given that chemical i is a mutagen in this combination, will yield a result judged positive by the decision rule; and, by assumption, T > p for all i that correspond to mutagens.
MKR reason that p is presumably constant for all nonmutagens tested with a given strain and activation, but that T clearly depends upon a mutagen's potency and toxicity for a given strain and activation. Nevertheless, they argue that the paucity of information regarding the behavior of a given chemical for a specific strain and activation suggests as a first approximation assuming T to be constant across all mutagens for a given strain and activation. Moreover, zi may be viewed as a Bernoulli trial with pr{zi = 1} = x, where i represents the proportion of nonmutagens among the chemicals selected for testing. With this construct, the results of applying a decision rule to data from M test chemicals for a particular strain-activation are given by {Yi;ni}'M= 1 with attendant log-likelihood 1 specified by: M l = 2 log {H1b(Yi;ni,p) + (1 -HI)b(Yi;ni,)} (8) They then construct a version of the EM algorithm (20) for the MLEs of (rr, p, i). Using results of Louis (21), MKR also obtain the observed information matrix for the parameters, and so produce estimates of the precision of the MLEs as well. MKR apply their analytic technique to two decision rules. The first is a modified statistical analysis based on the mechanistic models of Margolin et al. (8) , while the second is really not a rule, but rather a set of decisions arrived at by a senior NTP toxicologist upon his review of the experimental data.
In the present paper, the same technique is applied to a decision rule that has been widely employed in toxicology, but poorly understood. Labeled the "twotimes background" rule, this rule declares a chemical mutagenic if the average response for at least one dose of test chemical is greater than twice the observed concurrent control mean. This rule, which has a long history of application, is indifferent to the number of doses tested, the number of replicates observed per dose, any empirical measure of variability, and any consideration of level of significance. The results of applying the MKR technique to the decisions of the "two-times background" rule with regard to the NTP database are in Table 3 . Estimates ± one standard deviation of the proportion of mutagens among chemicals tested, the false positive probability, and the true positive probability for the "two-times background" rule by strain and activation.
Proportion of Probability Probability Table 3 . As one might well predict intuitively, this rule is moderately conservative, yielding false positive rates of approximately 0.01 for TA100 and 0.02 for TA98 and TA1535, irrespective of activation level. For TA1537, however, with its very low background rates, this rule has a false-positive rate of approximately 0.07. These estimates apply to the NTP protocol as executed by the NTP contractual laboratories, and to no other context. If one requires a repeated positive result for confirmation, then the probability of a falsely confirmed positive is p2. For TA100, TA98, and TA1535, this probability is estimated to be 1 x 10-4 to 4 x 10-4. For the NTP screening program, in which scientific judgment in chemical nomination and selection produces a population of test chemicals highly enriched with mutagens, decision rules with probabilities of confirmed false positives on the order of 10' are too conservative and counterproductive. The attendant loss in sensitivity to detect weak mutagens is a heavy price to pay in order to obtain a simple rule of thumb. In many instances, mutagens may not be able to achieve a doubling of background levels because of toxicity, solubility or other limitations, yet they may well exhibit highly reproducible patterns of mutation induction. An excellent example of this phenomenon is phenobarbital (22) .
Concluding Remark
The statistical studies briefly surveyed here all had their origins in problems that arose from genetic toxicology. From this survey, one conclusion is clear: genetic toxicology represents a rapidly growing area of science that is rich with research opportunities for statisticians.
